|
|
Session 6: Drug Discovery Case Studies of Major Diseases (Cardiovascular, Diabetes, Alzheimer Disease, AIDS) |
Session Chair: Dr. Gary Grover, Director, Product Safety Laboratories, Eurofins Scientific, USA
Co-Chair: Dr. Jingwen Liu, senior scientist Palo Alto VA Health Care Systems |
|
|
Title: Human Monoclonal Antibodies against Viruses and Cancer
Dr. Xiaodong Xiao, Staff Scientist, Nanobiology Program, NCI, NIH, USA
|
|
Title: An Advance on the Obesity and Diabetes
Dr. Gary Grover, Director, Product Safety Laboratories, Eurofins Scientific, USA
|
|
Title: Upregulation of Long-chain Acyl-CoA Synthetases: A Novel Cellular Mechanism for Triglyceride Reduction
Dr. Jingwen Liu, Senior Scientist Palo Alto VA Health Care Systems, USA
|
|
Title: Discovery and Function of a Super Interferon
Dr. Xinyuan Liu, Professor, member of CAS, China
|
|
Title: Investigating Neurodegenerative Diseases with Molecular Simulation
Dr. Paolo Carloni, International School for Advanced Studies, Italy
|
|
Title: Discovery of Small Cell-permeable Molecules that Inhibit Histone Acetyl Transferase (HAT) Enzyme
Dr. Roberto Di Santo, Associated Professor in Medicinal Chemistry, University of Rome, Italy
|
|
Title: Discovery of Minozac: a Disease-Modifying drug candidate for Alzheimer's disease
Dr. Wenhui Hu, Currently Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China |
|
